Newsletter

Leap Handcrafted Vodka

Total Labels 1
Approved 1
Expired 0

Gray Duck Spirits, Gray Duck Spirits LLC — Burnsville, MN

Minnesota

About Leap Handcrafted Vodka

Leap Handcrafted Vodka is a vodka brand produced in Minnesota and registered with the Alcohol and Tobacco Tax and Trade Bureau. The spirit is bottled at a proof level between 80 and 89 proof. According to TTB public records, the brand received its initial label approval in 2022. The product line currently consists of one distinct offering within the vodka category. As a Minnesota-based vodka, Leap Handcrafted Vodka represents the state's participation in the broader American spirits market. The brand maintains a single TTB label approval on file, reflecting its current product portfolio. The designation of "handcrafted" in the brand name suggests an artisanal approach to production, though specific production methodologies remain beyond the scope of publicly available TTB documentation. The vodka's proof range places it within the standard category for spirits of its type, offering consumers a spirit in the typical strength range for vodka products. Minnesota's establishment as the origin state indicates the brand's regional identity within the United States spirits industry.

Filter by:
Displaying 1 results
Label Name Spirit Type Status Approval Date Producer
Vodka 80-89 Proof
Leap Handcrafted Vodka

VODKA 80-89 PROOF

Vodka 80-89 Proof Approved 2022-07-04 Gray Duck Spirits, Gray Duck Spirits LLC

Page 1 of 1

1

Leap Handcrafted Vodka at a Glance

Leap Handcrafted Vodka has 1 distinct product with 1 total TTB label approvals, including Vodka 80-89 Proof. Labels approved between 2022-07-04 and 2022-07-04. Produced in Minnesota.

All information sourced from public TTB records.

Are you the owner or distributor of Leap Handcrafted Vodka?

Claim this brand listing to update information or get featured. Contact team@buy.vodka.

Produced At

Gray Duck Spirits, Gray Duck Spirits LLC

Related Brands

Related Questions

Browse All Labels

Stay informed

Newsletter coming soon.

Follow us on X for new approvals, launches, and industry intelligence.